Hydrophobic acrylic IOLs offer better low contrast visual acuity


Hydrophobic acrylic IOLs give the best optical quality in pseudophakic eyes.

A study featured in the Journal of Cataract and Refractive Surgery has identified that hydrophobic acrylic IOLs give the best optical quality in pseudophakic eyes.

The comparative case series, led by Dr Mayank A. Nanavaty, St Thomas' Hospital, London, UK, involved 28 eyes fitted with hydrophilic IOLs and 43 with hydrophobic IOLs. All eyes had a clear posterior capsule within the central 4 mm and were assessed 3 months postoperatively. Outcome measures included the 10% and 50% point-spread function (PSF) values and in vitro forward-scattering.

There was no considerable difference in IOL power, postoperative spherical equivalent or 100% logMAR correct distance visual acuities (CDVA).

Between the IOL groups the results for 9% logMAR CDVA and 10% PSF, 50% PSF and Zernike polynomial were significantly different. It was found that hydrophilic IOLs had more forward scatter.

Overall, the hydrophobic acrylic IOL produced greater optical quality and better low contrast visual acuity compared to the hydrophilic IOL. The study suggests the material of the IOL should be considered for pseudophakic eyes.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.